Optometrist · Phila, PA
NPI
1073640868
Since 2007
Specialty
Optometrist
Code 152W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3400 Aramingo Ave, Pearle
Phila, PA, 19134
Phone (215) 425-4340
Medicare paid, 2024
$6,318
89 services
Medicare patients, 2024
44
Average age 68
Drug cost, 2024
$897K
2,120 prescriptions
Company payments, 2025
$615
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Doray I Gurkaynak was code 99214 (office e&m - established), 28 times for 19 patients. In total Doray I Gurkaynak billed 89 services in 8 codes, and Medicare paid $6,318.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 28 | 19 | $93.89 | $2,629 |
| 92250 Angiography | Office | 18 | 18 | $24.58 | $442 |
| 92004 Ophthalmological E&M | Office | 15 | 15 | $68.39 | $1,026 |
By year: 2022 $13K for 151 services; 2023 $5,043 for 71 services; 2024 $6,318 for 89 services.
Medicare prescription drug claims, 2024
In 2024, the drug Doray I Gurkaynak prescribed most often to Medicare patients was Restasis (Cyclosporine), with 763 prescriptions and refills. In total Doray I Gurkaynak wrote 2,120 Medicare prescriptions that cost $897K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 763 | 777 | 213 | $477K |
| Cyclosporine Generic | 235 | 239 | 83 | $57K |
| Xiidra Lifitegrast | 231 | 233 | 79 | $158K |
| Latanoprost Generic | 151 | 173 | 33 | $1,604 |
| Cequa Cyclosporine | 138 | 140 | 53 | $78K |
| Eysuvis Loteprednol Etabonate | 94 | 99 | 42 | $44K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 81 | 81 | 42 | $980 |
| Zylet Tobramycin/Lotepred Etab | 56 | 56 | 33 | $18K |
| Simbrinza Brinzolamide/Brimonidine Tart | 42 | 54 | Under 11 | $8,320 |
| Timolol Maleate Generic | 41 | 48 | Under 11 | $236 |
| Erythromycin Erythromycin Base | 37 | 37 | 11 | $346 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 34 | 34 | 20 | $1,622 |
| Lumigan Bimatoprost | 31 | 34 | 11 | $10K |
| Loteprednol Etabonate Generic | 28 | 28 | 12 | $3,479 |
| Travoprost Generic | 22 | 32 | Under 11 | $4,138 |
Brand drugs: 1,665 claims; generic drugs: 455 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Doray I Gurkaynak $615 ($615 in general payments such as food, travel and fees) from 4 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 12 | $273 |
| Alcon Vision LLC ALC | 10 | $254 |
| Dompe US, Inc. | 2 | $54.29 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $33.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.